The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.

The novel design of AtaCor's Atala™ lead aims to provide reliable sensing, antitachycardia pacing (ATP), and shock therapies ...

AtaCor Medical announced today that it entered a financing worth up to $75 million to support its U.S. FDA pivotal study.

For cardiac electrophysiologists (EPs), pulsed field ablation (PFA) is undoubtedly the most disruptive technology in recent memory. The pre-conference PFA Live Case Summit showcased the novel use of ...

Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ...

The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately to severely active ulcerative colitis. Perspective from David T. Rubin, MD The approval ...

Each year, ICD-10-CM is updated on Oct. 1. For 2026, there are 74,179 total codes, 487 additions, 28 deletions, and 38 ...

A vein treatment at a clinic owned by a celebrity surgeon has left a Long Island councilwoman in crippling agony, after she was given a procedure she never agreed to that was painfully botched, a new ...

"Historically, IL-23 inhibitors have required IV infusions at the start of therapy, which can create barriers to starting treatment or be burdensome for some patients and clinicians," said David T.

Here are the latest updates on OU's stadium policies and procedures for fans entering Gaylord Family-Oklahoma Memorial Stadium for this week's game. Beer and other ready-to-drink alcoholic beverages ...